{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:54:50Z","timestamp":1792594490038,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010321","name":"Oogfonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jval.2025.06.006","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T12:02:15Z","timestamp":1750939335000},"page":"1317-1326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The Cost-Effectiveness of an Artificial Intelligence-Based Population-Wide Screening Program for Primary Open-Angle Glaucoma in The Netherlands"],"prefix":"10.1016","volume":"28","author":[{"given":"Bart-Jan","family":"Boverhof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Corro Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen A.","family":"Vermeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor A.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline C.W.","family":"Klaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wishal D.","family":"Ramdas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans G.","family":"Lemij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Rutten-van M\u00f6lken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jval.2025.06.006_bib1","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of Glaucoma Burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.jval.2025.06.006_bib2","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"3","key":"10.1016\/j.jval.2025.06.006_bib3","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/sj.eye.6702637","article-title":"Cost-effectiveness of early detection and treatment of ocular hypertension and primary open-angle glaucoma by the ophthalmologist","volume":"22","author":"Peeters","year":"2008","journal-title":"Eye"},{"issue":"5","key":"10.1016\/j.jval.2025.06.006_bib4","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.eye.6702284","article-title":"Lifetime visual prognosis for patients with primary open-angle glaucoma","volume":"21","author":"Ang","year":"2007","journal-title":"Eye"},{"issue":"8","key":"10.1016\/j.jval.2025.06.006_bib5","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1755-3768.2012.02555.x","article-title":"Prevalence of end-of-life visual impairment in patients followed for glaucoma","volume":"91","author":"Ernest","year":"2013","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"10.1016\/j.jval.2025.06.006_bib6","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1442-9071.2011.02559.x","article-title":"Lifetime visual prognosis of patients with glaucoma","volume":"39","author":"Goh","year":"2011","journal-title":"Clin Experiment Ophthalmol"},{"issue":"3","key":"10.1016\/j.jval.2025.06.006_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/IJG.0b013e318033500f","article-title":"Lifetime visual disability in open-angle glaucoma and ocular hypertension","volume":"16","author":"Forsman","year":"2007","journal-title":"J Glaucoma"},{"issue":"1","key":"10.1016\/j.jval.2025.06.006_bib8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1167\/iovs.13-13006","article-title":"Examining visual field loss in patients in glaucoma clinics during their predicted remaining lifetime","volume":"55","author":"Saunders","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.jval.2025.06.006_bib9","first-page":"2803","article-title":"Mobility performance in glaucoma","volume":"40","author":"Turano","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.jval.2025.06.006_bib10","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1001\/archopht.119.12.1788","article-title":"Prevalence and causes of visual field loss in the elderly and associations with impairment in daily functioning: the Rotterdam study","volume":"119","author":"Ramrattan","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jval.2025.06.006_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ajo.2018.12.021","article-title":"Predictors of falls per step and falls per year at and away from home in glaucoma","volume":"200","author":"Ramulu","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.jval.2025.06.006_bib13","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.ophtha.2004.01.029","article-title":"Detection of undiagnosed glaucoma by eye health professionals","volume":"111","author":"Wong","year":"2004","journal-title":"Ophthalmology"},{"issue":"41","key":"10.1016\/j.jval.2025.06.006_bib14","doi-asserted-by":"crossref","DOI":"10.3310\/hta11410","article-title":"The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation","volume":"11","author":"Burr","year":"2007","journal-title":"Health Technol Assess"},{"issue":"1","key":"10.1016\/j.jval.2025.06.006_bib15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1355819613499748","article-title":"Is it worthwhile to conduct a randomized controlled trial of glaucoma screening in the United Kingdom?","volume":"19","author":"Burr","year":"2014","journal-title":"J Health Serv Res Policy"},{"issue":"02","key":"10.1016\/j.jval.2025.06.006_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1017\/S0266462308080288","article-title":"Economic evaluation of screening for open-angle glaucoma","volume":"24","author":"Hern\u00e1ndez","year":"2008","journal-title":"Int J Technol Assess Health Care"},{"issue":"2","key":"10.1016\/j.jval.2025.06.006_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1167\/tvst.9.2.55","article-title":"Artificial intelligence algorithms to diagnose glaucoma and detect glaucoma progression: translation to clinical practice","volume":"9","author":"Mursch-Edlmayr","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"10.1016\/j.jval.2025.06.006_bib18","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1109\/TMI.2023.3313786","article-title":"AIROGS: artificial intelligence for robust glaucoma screening challenge","volume":"43","author":"de Vente","year":"2024","journal-title":"IEEE Trans Med Imaging"},{"issue":"suppl 75","key":"10.1016\/j.jval.2025.06.006_bib19","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1097\/IJG.0000000000002449","article-title":"Screening of glaucoma: consensus and directions","volume":"33","author":"Moghimi","year":"2024","journal-title":"J Glaucoma"},{"issue":"suppl 67","key":"10.1016\/j.jval.2025.06.006_bib20","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1097\/IJG.0000000000002416","article-title":"How do we pay for glaucoma screening?","volume":"33","author":"Ramachandran","year":"2024","journal-title":"J Glaucoma"},{"issue":"suppl 33","key":"10.1016\/j.jval.2025.06.006_bib21","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/IJG.0000000000002404","article-title":"Barriers and potential solutions to glaucoma screening in the developing world: a review","volume":"33","author":"Meethal","year":"2024","journal-title":"J Glaucoma"},{"issue":"suppl 26","key":"10.1016\/j.jval.2025.06.006_bib22","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/IJG.0000000000002367","article-title":"Novel technologies in artificial intelligence and telemedicine for glaucoma screening","volume":"33","author":"Christopher","year":"2024","journal-title":"J Glaucoma"},{"issue":"suppl 1","key":"10.1016\/j.jval.2025.06.006_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bjophthalmol-2021-egsguidelines","article-title":"European Glaucoma Society Terminology and Guidelines for Glaucoma, 5th Edition","volume":"105","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"9975","key":"10.1016\/j.jval.2025.06.006_bib26","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(14)62111-5","article-title":"Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial","volume":"385","author":"Garway-Heath","year":"2015","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jval.2025.06.006_bib27","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s40273-019-00844-y","article-title":"TECH-VER: a verification checklist to reduce errors in models and improve their credibility","volume":"37","author":"B\u00fcy\u00fckkaramikli","year":"2019","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"10.1016\/j.jval.2025.06.006_bib28","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jval.2024.05.006","article-title":"Consolidated health economic evaluation reporting standards for interventions that use artificial intelligence (CHEERS-AI)","volume":"27","author":"Elvidge","year":"2024","journal-title":"Value Health"},{"issue":"9","key":"10.1016\/j.jval.2025.06.006_bib30","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10654-017-0321-4","article-title":"The Rotterdam Study: 2018 update on objectives, design and main results","volume":"32","author":"Ikram","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jval.2025.06.006_bib31","article-title":"Glaucoma and intraocular pressure in EPIC-Norfolk Eye Study: cross sectional study","volume":"358","author":"Chan","year":"2017","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.jval.2025.06.006_bib32","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ophtha.2013.01.043","article-title":"Prevalence and severity of undetected manifest glaucoma. Results from the Early Manifest Glaucoma Trial screening","volume":"120","author":"Heijl","year":"2013","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.jval.2025.06.006_bib33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ajo.2007.06.029","article-title":"Prevalence of open-angle glaucoma in Greece: the Thessaloniki eye study","volume":"144","author":"Topouzis","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jval.2025.06.006_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/IJG.0000000000002132","article-title":"Cost-effectiveness of screening for open angle glaucoma compared with opportunistic case finding","volume":"32","author":"Anton","year":"2023","journal-title":"J Glaucoma"},{"issue":"12","key":"10.1016\/j.jval.2025.06.006_bib36","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.ophtha.2009.06.042","article-title":"Natural history of open-angle glaucoma","volume":"116","author":"Heijl","year":"2009","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.jval.2025.06.006_bib37","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1034\/j.1600-0420.2003.00070.x","article-title":"Measuring visual field progression in the Early Manifest Glaucoma Trial","volume":"81","author":"Heijl","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.jval.2025.06.006_bib38","author":"Crabb"},{"issue":"4","key":"10.1016\/j.jval.2025.06.006_bib39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000350553","article-title":"Health- and vision-related quality of life in patients with ocular hypertension or primary open-angle glaucoma","volume":"229","author":"Wolfram","year":"2013","journal-title":"Ophthalmologica"},{"issue":"2","key":"10.1016\/j.jval.2025.06.006_bib40","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/0272989X15578127","article-title":"Mapping between 6 multiattribute utility instruments","volume":"36","author":"Chen","year":"2016","journal-title":"Med Decis Mak"},{"key":"10.1016\/j.jval.2025.06.006_bib41","author":"Alava"},{"issue":"5","key":"10.1016\/j.jval.2025.06.006_bib42","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/gutjnl-2011-301917","article-title":"Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening","volume":"62","author":"Goede","year":"2013","journal-title":"Gut"},{"issue":"1063","key":"10.1016\/j.jval.2025.06.006_bib43","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150910","article-title":"The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis","volume":"89","author":"Greuter","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jval.2025.06.006_bib44","author":"Hakkaart-van Roijen"},{"issue":"1","key":"10.1016\/j.jval.2025.06.006_bib48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10198-019-01115-5","article-title":"Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study","volume":"21","author":"Chuvarayan","year":"2020","journal-title":"Eur J Health Econ"},{"issue":"7","key":"10.1016\/j.jval.2025.06.006_bib49","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1167\/iovs.14-14643","article-title":"Rates of glaucomatous visual field change in a large clinical population","volume":"55","author":"Chauhan","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jval.2025.06.006_bib50","author":"Ministerie van Volksgezondheid"},{"issue":"6","key":"10.1016\/j.jval.2025.06.006_bib51","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1167\/iovs.14-14014","article-title":"A comparative effectiveness analysis of visual field outcomes after projected glaucoma screening using SD-OCT in African American communities","volume":"55","author":"Blumberg","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.jval.2025.06.006_bib52","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1038\/s41433-022-02346-2","article-title":"Cost-effectiveness of polygenic risk profiling for primary open-angle glaucoma in the United Kingdom and Australia","volume":"37","author":"Liu","year":"2023","journal-title":"Eye (Lond)"},{"issue":"3","key":"10.1016\/j.jval.2025.06.006_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100300","article-title":"Characteristics of a large, labeled data set for the training of artificial intelligence for glaucoma screening with fundus photographs","volume":"3","author":"Lemij","year":"2023","journal-title":"Ophthalmol Sci"},{"issue":"7","key":"10.1016\/j.jval.2025.06.006_bib54","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jamaophthalmol.2022.1435","article-title":"Association of diabetes medication with open-angle glaucoma, age-related macular degeneration, and cataract in the Rotterdam study","volume":"140","author":"Vergroesen","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.jval.2025.06.006_bib55","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13244-023-01599-z","article-title":"Radiology AI Deployment and Assessment Rubric (RADAR) to bring value-based AI into radiological practice","volume":"15","author":"Boverhof","year":"2024","journal-title":"Insights Imaging"},{"issue":"2","key":"10.1016\/j.jval.2025.06.006_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.hlpt.2024.100868","article-title":"Broadening the HTA of medical AI: a review of the literature to inform a tailored approach","volume":"13","author":"Boverhof","year":"2024","journal-title":"Health Policy Technol"},{"issue":"10","key":"10.1016\/j.jval.2025.06.006_bib57","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1167\/iovs.12-11185","article-title":"Robust and censored modeling and prediction of progression in glaucomatous visual fields","volume":"54","author":"Bryan","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525024106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525024106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:13:05Z","timestamp":1777608785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301525024106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1098301525024106"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2025.06.006","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Cost-Effectiveness of an Artificial Intelligence-Based Population-Wide Screening Program for Primary Open-Angle Glaucoma in The Netherlands","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2025.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}